Highlighted transactions

Healthcare

 

Medtronic, PLC

Medtronic plc (NYSE: MDT) entered a definitive agreement with Cardinal Health, Inc. (NYSE: CAH) to sell its patient care, deep vein thrombosis and nutritional insufficiency businesses within the patient monitoring & recovery (PMR) division of Medtronic's minimally invasive therapies group (MITG). Piper Jaffray served as the lead financial advisor to Medtronic.

Client Description

Medtronic develops therapeutic and diagnostic medical products that are sold worldwide. The company's principal products include those for cardiac and vascular, minimally invasive technologies, restorative therapies and diabetes. Medtronic was founded in 1949 and is headquartered in Dublin, Ireland.

Counterparty Description

Cardinal Health, Inc. is a $125B+ revenue, globally integrated healthcare services and products company, providing customized solutions for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide.

Back